Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme

Clinical trial NCT00979017 · COMPLETED

Trial details

NCT number: NCT00979017
Sponsor: Katy Peters
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Gliosarcoma

Start date: 2009-11-01
Primary completion: 2011-02-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.